Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
This is a single-center, double-blind, inpatient study followed by an outpatient,
placebo-controlled, multiple-IV injection evaluation of the safety and tolerability of
PPI-1019 in subjects with mild-moderate Alzheimer's disease (AD). The primary objective of
the study is to assess the safety of multiple IV injections of PPI-1019 in subjects with
mild-moderate Alzheimer's disease.